These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16409450)

  • 1. Adding the vessel wall to Virchow's triad.
    Mann KG
    J Thromb Haemost; 2006 Jan; 4(1):58-9. PubMed ID: 16409450
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further reflections on Virchow's triad.
    Malone PC
    South Med J; 2005 Jan; 98(1):125; author reply 126. PubMed ID: 15678651
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric thrombophilia.
    Yang JY; Chan AK
    Pediatr Clin North Am; 2013 Dec; 60(6):1443-62. PubMed ID: 24237981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virchow's triad revisited: blood constituents.
    Chung I; Lip GY
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):449-54. PubMed ID: 15692259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets.
    Blann AD; Lip GY
    Thromb Res; 2001 Feb; 101(4):321-7. PubMed ID: 11320984
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Messmore HL
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():13-20. PubMed ID: 11155190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How a damaged blood vessel wall contibutes to thrombosis and hypertenasion.
    Blann AD
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):445-8. PubMed ID: 15692258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeostasis of Hemostasis: The Role of Endothelium.
    Kazmi RS; Boyce S; Lwaleed BA
    Semin Thromb Hemost; 2015 Sep; 41(6):549-55. PubMed ID: 26270112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.
    Wolberg AS; Aleman MM; Leiderman K; Machlus KR
    Anesth Analg; 2012 Feb; 114(2):275-85. PubMed ID: 22104070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial disease and Virchow's triad.
    Bennett PC; Silverman SH; Gill PS; Lip GY
    Thromb Haemost; 2009 Jun; 101(6):1032-40. PubMed ID: 19492144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor.
    Tobu M; Iqbal O; Fareed D; Chatha M; Hoppensteadt D; Bansal V; Fareed J
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):225-32. PubMed ID: 15247979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute coronary syndromes: Virchow's triad revisited.
    Lee KW; Lip GY
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):605-25. PubMed ID: 14517485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is 'Virchow's triad' useful?
    Malone PC; Agutter PS
    Br J Haematol; 2009 Jun; 145(6):839; author reply 840-1. PubMed ID: 19344411
    [No Abstract]   [Full Text] [Related]  

  • 16. Virchow's triad revisited: abnormal flow.
    Lowe GD
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):455-7. PubMed ID: 15692260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virchow's triad: the vascular basis of cerebral injury.
    del Zoppo GJ
    Rev Neurol Dis; 2008; 5 Suppl 1(Suppl 1):S12-21. PubMed ID: 18645567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking the contributing risk factors in venous thrombosis in terms of therapeutic potential: Virchow's triad revisited.
    Kiyomura M; Katayama T; Kusanagi Y; Ito M
    J Obstet Gynaecol Res; 2006 Apr; 32(2):216-23. PubMed ID: 16594928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
    Horowitz NA; Brenner B
    Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation update: what's new in hemostasis testing?
    Favaloro EJ; Lippi G
    Thromb Res; 2011 Jan; 127 Suppl 2():S13-6. PubMed ID: 21193107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.